Steatosis severity was associated with upregulation of COL5A3 and TP53I3, whereas upregulated RASGEF1B, S100A12, and TGFBR3 were linked to early-stage liver steatosis (Figure 7A). Here, RASGEF1B is linked to fatty liver disease.